AstraZeneca hikes forecasts amid Pfizer bid fallout By: CNBC.com News July 31, 2014 at 02:25 AM EDT AstraZeneca claimed to have "one of the most exciting pipelines" in the pharmaceutical industry, as it reported a second-quarter revenue rise. Read More >> Related Stocks: Almirall Sa Astrazeneca Plc ADR Pfizer